|
Recommendations
for secondary prevention of AF with
‘upstream’ therapy |
|
|
|
Recommendations |
Evidencia |
Pre-treatment with ACEIs and ARBs may be considered in
patients
with recurrent AF and receiving antiarrhythmic drug therapy. |
IIb B |
ARBs or ACEIs may be useful for prevention of recurrent
paroxysmal
AF or in patients with persistent AF undergoing electrical
cardioversion
in the absence of significant structural heart disease if
these
agents are indicated for other reasons (e.g. hypertension). |
IIb B |
ACEI: angiotensin-converting enzyme inhibitor; AF.: atrial
fibrillation; ARB:
angiotensin receptor blocker. |
|
 |